Bhekisisa: More HIV prevention choices may boost user uptake

A new once-a-month HIV prevention pill is moving into the final stage of testing. But early South African uptake data of the six-monthly anti-HIV jab suggest the biggest breakthrough may not be a new medicine – it may be giving people more ways to protect themselves.